Drug intelligence / Profile preview

bedrobinol

Development stage
Unknown
Lead developer
Bedrocan
Modality
Small Molecules
Administration
Inhalation, Oral
01

Overview

Bedrobinol is a standardized medicinal cannabis chemovar developed by Bedrocan International. It is derived from the *Cannabis sativa* L. cultivar 'Ludina' and is produced under EU GMP standards as a pharmaceutical-grade active pharmaceutical ingredient (API) and botanical raw material. The product contains approximately 13.5% THC (tetrahydrocannabinol) and less than 1.0% CBD (cannabidiol). It is primarily used in clinical research and medicinal cannabis programs for conditions such as pain relief and appetite stimulation in advanced cancer-related anorexia. As a botanical raw material, its therapeutic effects are mediated by the interaction of cannabinoids, primarily THC, with the endocannabinoid system. Bedrobinol is supplied in various forms including flos (whole dried flower), cut flos, and industrial forms for further processing.

Brand names
Bedrobinol
Other names
Cannabis sativa L. LudinaLudina
02

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on bedrobinol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bedrobinol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call